ArticleJournal of the National Cancer Center2026

ACLY blockade rewires tumor metabolism to boost immunity in MASH-driven hepatic cell carcinoma.

Yidi Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.